Proadrenomedullin NH2-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells

Peptides

Volumn 21, Issue 1, 2000, Pages 101-107

  Moody, T W ^a   Coy, D ^b   Cuttitta, F ^a   Montuenga, L M ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adrenomedullin; C fos mRNA; cAMP; Growth; PAMP; Receptors

Indexed keywords

ADRENOMEDULLIN; AMYLIN; CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP; MESSENGER RNA; PROADRENOMEDULLIN; THYMIDINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; TERATOCARCINOMA;

ADRENOMEDULLIN; BINDING, COMPETITIVE; CALCITONIN GENE-RELATED PEPTIDE; CELL DIVISION; CYCLIC AMP; GENES, FOS; HUMANS; KINETICS; PEPTIDE FRAGMENTS; PEPTIDES; PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TERATOCARCINOMA; TUMOR CELLS, CULTURED;

EID: 0033994208     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00178-3     Document Type: Article

References (43)

1. Aiyar N., Rand K., Elshourbagy N.A., Zeng X., Adamou J.E., Bergsma D.J., Li Y. cDNA encoding the calcitonin gene related peptide type I receptor. J Biol Chem. 271:1996;11325-11329.
2. Ando K. Proadrenomedullin N-terminal 20 peptide (PAMP) inhibits proliferation of human neuroblastoma TGW cells. FEBS Lett. 413:1997;462-466.
3. Bell G., Resine T. Molecular biology of somatostatin receptors. Trends Neurosci. 16:1993;34-38.
4. 2-terminal 20 peptide has cAMP mediated vasodilator activity in the mesenteric vascular bed of the cat. Peptides. 17:1996;1379-1387.
5. Eguchi S., Hirata Y., Iwasake H., Sato K., Watanabe T.X., Inui T., Nakajima K., Sakakibara S., Marumo F. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology. 136:1994;2454-2458.
6. Gerbaud P., Segond N., Moukhtar M.S., Evian-Brion D. Calcitonin and calcitonin gene-related peptide are chemotactic for embryonal carcinoma cells. Endocrinology. 129:1991;2530-2534.
7. Ichiki Y., Kitamura K., Kangawa K., Kawamoto M., Matsuo H., Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 338:1994;6-10.
8. Ishizaka Y., Tanaka M., Kitamura K., Kangawa K., Minimino N., Matsuo H., Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Comm. 200:1994;642-646.
9. Iwasaki H., Hirata Y., Iwashina M., Sato K., Marumo F. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat. Endocrinology. 137:1996;3045-3050.
10. Kapas S., Catt K.J., Clark J.L. Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J. Biol. Chem. 270:1995;25344-25347.
11. Kapas S., Clark A.J. Identification of an orphan receptor gene as a type 1 calcitonin gene related peptide receptor. Biochem Biophys Res Comm. 217:1995;832-838.
12. Katoh F., Kitamura K., Niina H., Yamamoto R., Washimine H., Kangawa K., Yamamota Y., Kobayashi H., Eto I., Wada A. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide its exocylotic secretion and inhibition of catecholamine secretion in adrenal medulla . J Neurochem. 64:1995;459-461.
13. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin. A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Comm. 192:1993;553-560.
14. Kitamura K., Sakata J., Dangawa K.J., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Comm. 194:1993;720-725.
15. Kitamura K., Kangawa K., Ishiyama Y., Washimine H., Ichiki Y., Kawamoto M., Minamino N., Matsuo H., Eto T. Identification and hypotensive action of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett. 351:1994;35-37.
16. Korman L.Y., Carney D.N., Citron M.L., Moody T.W. Secretin/VIP stimulated secretion of bombesin-like peptides from human small cell lung cancer. Cancer Res. 46:1986;1214-1218.
17. Martinez A., Miller M.J., Unsworth E.J., Siegfried J.M., Cuttitta F. Expression of adrenomedullin in normal human lung and in pulmonary tumors. J Histochem Cytochem. 45:1997;159-164.
18. Martinez A., Miller M.J., Catt K.J., Cuttitta F. Adrenomedullin receptor expression in human lung and in pulmonary tumors. J Histochem Cytochem. 45:1997;159-164.
19. Martinez A., Elsasser T.H., Muro-Cacho C., Moody T.W., Miller M.J., Macri C., Cuttitta F. Expression of adrenomedullin and its receptor in normal and malignant human skin a potential pluripotent role in the integument . Endocrinology. 138:1997;5597-5604.
20. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like protein. Nature. 393:1998;333-339.
21. Miller M.J., Martinez A., Unsworth E.J., Thiele C.J., Moody T.W., Cuttitta F. Adrenomedullin expression in human tumor cell lines and its potential role as an autocrine growth factor. J Biol Chem. 271:1996;23345-23351.
22. Montuenga L.M., Martinez A., Miller M.J., Unsworth E.J., Cuttitta F. Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action. Endocrinology. 138:1997;440-451.
23. Moody T.W., Miller M.J., Martinez A., Unsworth E., Cuttitta F. Adrenomedullin binds with high affinity, elevates cAMP and stimulates c-fos expression in C6 glioma cells. Peptides. 18:1997;1111-1115.
24. Muff R., Born W., Fischer J.A. Calcitonin, calcitonin gene related peptide, adrenomedullin and amylin homologous peptides, separate receptors and overlapping biological actions . Eur J Endocrinol. 133:1995;17-20.
25. Nanda K.A., Taylor G.M., Smith D.M., Owji A.A., Byfield P.G., Ghatei M.A., Bloom S.R. Specific adrenomedullin binding sites and hypotension in the rat systemic vascular bed. Regul Pept. 62:1996;145-151.
26. Owji A.A., Gardiner J.V., Upton P.D., Mahmoodi M., Ghatei M.A., Bloom S.R., Smith D.M. Characterization and molecular identification of adrenomedullin binding sites in the rat spinal cord a comparison with calcitonin gene related peptide receptors . J Neurochem. 67:1996;2172-2179.
27. Owji A.A., Smith D.M., Coppock H.A., Morgan D.G., Bhogal R., Ghatei M.A., Bloom S.R. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 136:1995;2127-2134.
28. Samson W.K., Murphy T., Schell D.A. A novel vasoactive peptide, adrenomedullin inhibits pituitary adrenocorticotropin release. Endocrinology. 136:1995;2349-2352.
29. 2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. Hypertension. 30:1997;10009-10014.
30. Satoh F., Takahashi K., Murakami O. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma, and neuroblastoma. J Clin Endocrinol Metab. 80:1995;1750-1752.
31. Segond N., Gerbaud P., Taboulet J., Jullienne A., Moukhtar M.S., Evian-Brion D. Retinoic acid abolishes the calcitonin gene-related peptide autocrine system in F9 teratocarcinoma cells. J Cell Biochem. 64:1997;447-457.
32. Schell D., Vari R., Samson W. Adrenomedullin. A newly discovered hormone controlling fluid and electrolyte homeostasis. Trends Exp Med. 7:1996;7-12.
33. Segond N., Gerbaud P., Cressent J., Lasmoles F., Taboulet J., Julienne A., Raynaud F., Moukhtar M.S., Evain-Brion D. Calcitonin gene-related peptide an autocrine growth factor with regulatory activity in vitro . Biochem Biophys Res Comm. 187:1992;381-388.
34. 2+ mobilization in bovine aortic endothelial cells. J Biol Chem. 270:1995;4412-4417.
35. Strickland S., Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 15:1978;393-403.
36. Takona K. Inhibitory effects of proadrenomedullin N-terminal 20 peptide on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs. J Pharmacol Exp Ther. 288:1999;522-528.
37. 2+ channel current through a pertussis toxin-sensitive G protein in rat pheochromocytoma-derived PC 12 cells. J Clin Invest. 98:1996;14-17.
38. 125I)BHrAMY) specific binding sites in the rat brain. Can J Physiol Pharmacol. 73:1995;1084-1088.
39. Washimine H., Kitamura K., Ichiki Y., Yamamota Y., Kangawa K., Matsuo H., Eto T. Immunoreactive proadrenomedullin N-terminal peptide in human tissue, plasma and urine. Biochem Biophys Res Commun. 202:1994;1081-1087.
40. Whitmarsh A.J., Davies R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med. 74:1996;589-607.
41. Withers D.J., Coppock H.A., Seufferlein R., Smith D.M., Bloom S.R., Rozengurt E.A. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS Lett. 378:1996;83-87.
42. Yotsumoto S., Shimada T., Cui C.Y., Nakashima H., Fujiwara H., Koh M.S. Expression of adrenomedullin, a hypotensive peptide, in the trophoblast giant cells at the embryo implantation site in mouse. Dev Biol. 203:1998;264-275.
43. Zimmerman U., Fischer J.A., Muff R. Adrenomedullin and calcitonin gene-related peptide interact with the same receptor in cultured human neuroblastoma SK-N-MC cells. Peptides. 16:1995;421-424.